| Home > In process > Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations. > Access to Fulltext |
| Restricted | |||||||
DZNE-2026-00134
|
|||||||
| version 1 |
| ||||||